Status:

COMPLETED

Effects of Long Term Albumin 20% Administration in Patients With Cirrhosis and Ascites.

Lead Sponsor:

Instituto Grifols, S.A.

Collaborating Sponsors:

Hospital Clinic of Barcelona

Conditions:

Cirrhosis

Ascites

Eligibility:

All Genders

18-80 years

Phase:

PHASE4

Brief Summary

Effects of long term albumin administration on the cardiocirculatory and renal function and hepatic hemodynamics in patients with advanced cirrhosis and ascites.

Detailed Description

Pharmacodynamic study of pathophysiological nature to assess the effects of prolonged administration of human albumin in the cardiocirculatory and renal function and hepatic hemodynamics in patients w...

Eligibility Criteria

Inclusion

  • Age above 18 years and less than 80 years.
  • Diagnosis of liver cirrhosis by biopsy or by clinical, laboratory, or ultrasound.
  • Daily requirement of diuretics at least 200mg of spironolactone or 100mg of spironolactone and 40 mg of furosemide
  • Renal dysfunction defined by a plasma concentration of serum creatinine ≥ 1.2 mg / dl, blood urea nitrogen ≥ 25 mg / dl or a serum sodium concentration ≤ 130 mEq / L.

Exclusion

  • Refractory Ascites (paracentesis requirements over 1 month.
  • Neoplastic disease including liver cancer if it exceeds the Milan criteria (one nodule\> 5 cm or three nodules\> 3 cm).
  • History of transjugular intrahepatic portosystemic shunt (TIPS) or surgical shunt
  • Gastrointestinal bleeding or bacterial infection documented in the past 15 days.
  • Heart failure or structural heart disease.
  • Organic renal insufficiency(proteinuria, hematuria and / or ultrasound data nephropathy).
  • Moderate or severe lung chronic disease.
  • Transplant.
  • Infection with human immunodeficiency virus.
  • Active addiction to drugs.
  • Mental state that prevents the patient understand the nature, extent and consequences of the study, except for hepatic encephalopathy.
  • Pregnancy.

Key Trial Info

Start Date :

July 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2014

Estimated Enrollment :

33 Patients enrolled

Trial Details

Trial ID

NCT00968695

Start Date

July 1 2009

End Date

April 1 2014

Last Update

June 26 2019

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

Hospital Universitari Germans Trias i Pujol

Badalona, Barcelona, Spain, 08916

2

Hospital del Mar

Barcelona, Spain, 08003

3

Hospital de la Santa Creu i Sant Pau

Barcelona, Spain, 08025

4

Hospital Clínic of Barcelona

Barcelona, Spain, 08036